Clinical Trial Update: A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating PM8002 in combination with chemotherapy for small cell lung cancer. The study, sponsored by Biotheus Inc., is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• PM8002

Snippet

Sponsor: Biotheus Inc. | Conditions: SCLC | Phase 2 | Status: ACTIVE_NOT_RECRUITING